“Unjected” Dating App for Unvaccinated People Faces Backlash for Hosting Singles Meetups
A Denver, Colorado venue canceled an upcoming singles event called The Freedom Mixer for the unvaccinated community due to “safety concerns,” multiple news outlets have reported. The event, organized by Unjected, a dating app launched in 2021 and “built on creating health-conscious relationships with those who share like-minded values and the convictions to remain unvaccinated,” […]
U.S. Troops No Longer Required to Take Annual Flu Shot
U.S. Secretary of War Pete Hegseth announced on Apr. 21, 2026 that, effective immediately, military service members are no longer required to receive the annual flu vaccine. The update was shared in an Apr. 20 memorandum stating that the flu vaccine is now “voluntary for all active and reserve component service members, as well as […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]
Combination mRNA COVID-Influenza Shot Recommended by European Medicines Agency
The European Medicine Agency (EDA) has recommended marketing authorization for Moderna’s mCombriax mRNA (messenger ribonucleic acid) shot. The product, also known as mRNA-1083, is a genetically engineered biologic targeting both influenza and COVID-19. It builds on work Moderna has done on its next-generation mRNA COVID shot known as mNexSpike and mRNA-1010.1 2 3 The recommendation […]
FDA Refuses to Review Moderna’s mRNA Influenza Shot License Application
The U.S. Food and Drug Administration (FDA) has declined to accept for review Moderna’s Biologics License Application (BLA) for its mRNA-based seasonal influenza shot, citing concerns about the completeness of the submission. The decision highlights the agency’s commitment to maintaining clear evidentiary standards for approving the licensing of new vaccines.1 On Feb. 3, 2026, the […]